Makoto Ueno

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).

Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto et al. · Journal of Clinical Oncology · 2022 · 107 citations

Medicine, Cancer Biology, Oncology +17

Pemigatinib in previously treated solid tumors with activating FGFR1–FGFR3 alterations: phase 2 FIGHT-207 basket trial

Jordi Rodón, Silvia Damian, Muhammad Furqan et al. · Nature Medicine · 2024 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition

Masaharu Ishida, Tsutomu Fujii, Masashi Kishiwada et al. · Journal of Hepato-Biliary-Pancreatic Sciences · 2024 · 65 citations · Full text

Medicine, Oncology, Pathology +17

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Changhoon Yoo, Milind Javle, Helena Verdaguer Mata et al. · Hepatology · 2023 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Taito Fukushima, Manabu Morimoto, Satoshi Kobayashi et al. · The Oncologist · 2023 · 41 citations · Full text

Medicine, Oncology, Pharmacology +15